查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1306382

製藥器械組合藥物市場：按產品、用途和最終用戶 - 2023-2030 年全球預測

Drug Device Combination Products Market by Product, Application, End-user - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球醫藥器械組合藥物市場預計將以 7.52%的年複合成長率大幅成長，到 2023 年達到 1382.4 億美元，預計到 2030 年將達到驚人的 2307.1 億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球製藥器械組合藥物市場至關重要。通過檢查業務戰略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使用戶能夠根據自己的具體需求做出資訊的決策。這種高級分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市場佔有率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、積累和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發領域、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通貨膨脹的累積影響。

5、競爭評估與資訊：對主要企業的市場佔有率、戰略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評價。

6. 產品開發和創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1.全球醫藥器械組合藥物市場規模及預測是多少？

2.在預測期內，COVID-19 對全球製藥器械組合藥物市場的抑制要素和影響有哪些？

3. 在預測期內，全球醫藥器械組合藥物市場需要投資哪些產品/細分市場/應用/領域？

4.你們在全球醫藥器械組合藥物市場的競爭策略是什麼？

5.全球製藥器械組合藥物市場的技術趨勢和法律規範是什麼？

6.全球醫藥器械組合藥物市場主要供應商的市場佔有率是多少？

7. 哪些型態和戰略舉措被認為適合進入全球藥物器械組合藥物市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 促進因素
      • 美國慢性病和癌症的患病率不斷上升
      • 患者和醫生對微創手術越來越感興趣
      • 持續劑量特異性治療的替代方案
    • 抑制因素
      • 產品召回事件增加
    • 機會
      • 製藥器械組合藥物的研發
      • 製藥設備組合藥物技術的進步
    • 任務
      • 複雜性和不利的法規批准
  • 市場趨勢
  • COVID-19 的累積影響
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通貨膨脹的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範
  • 客戶客製化

第6章 藥品器械組合藥物市場：副產品

  • 抗菌導管
  • 藥物釋放型支架
  • 輸液泵
  • 吸入器
  • 整形外科組合產品
  • 光動力治療儀
  • 預充式注射器
  • 經皮吸收貼片
  • 創傷護理產品

第7章 藥品器械組合藥物市場：按用途

  • 抗菌用途
  • 癌症治療
  • 心血管疾病
  • 糖尿病
  • 呼吸系統的問題

第8章 製藥器械組合藥物市場：按最終用戶分類

  • 門診手術中心
  • 家庭護理設置
  • 醫院和診所

第9章 美洲醫藥器械組合藥物市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章 亞太醫藥器械組合藥物市場

  • 澳大利亞
  • 中國
  • 印度
  • 印度尼西亞
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲醫藥器械組合藥物市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 競爭情景分析：主要企業

第13章上市公司名單

第14章附錄

  • 討論指南
  • 關於許可和定價
Product Code: MRR-742BD517D8F6

The Global Drug Device Combination Products Market is forecasted to grow significantly, with a projected USD 138.24 billion in 2023 at a CAGR of 7.52% and expected to reach a staggering USD 230.71 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Drug Device Combination Products Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Drug Device Combination Products Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Antimicrobial Catheters, Drug Eluting Stents, Infusion Pumps, Inhalers, Orthopedic Combination Products, Photodynamic Therapy Devices, Prefilled Syringes, Transdermal Patches, and Wound Care Products. The Orthopedic Combination Products is projected to witness significant market share during forecast period.

Based on Application, market is studied across Antimicrobial Application, Cancer Treatment, Cardiovascular Disorder, Diabetes, and Respiratory Problem. The Antimicrobial Application is projected to witness significant market share during forecast period.

Based on End-user, market is studied across Ambulatory Surgery Centers, Home Care Settings, and Hospital & Clinic. The Home Care Settings is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Drug Device Combination Products Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Drug Device Combination Products Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Drug Device Combination Products Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Drug Device Combination Products Market?

4. What is the competitive strategic window for opportunities in the Global Drug Device Combination Products Market?

5. What are the technology trends and regulatory frameworks in the Global Drug Device Combination Products Market?

6. What is the market share of the leading vendors in the Global Drug Device Combination Products Market?

7. What modes and strategic moves are considered suitable for entering the Global Drug Device Combination Products Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Drug Device Combination Products Market, by Product, 2022 vs 2030
  • 4.3. Drug Device Combination Products Market, by Application, 2022 vs 2030
  • 4.4. Drug Device Combination Products Market, by End-user, 2022 vs 2030
  • 4.5. Drug Device Combination Products Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of chronic disease and cancer in the United States
      • 5.1.1.2. The growing patient and physician preference for minimally invasive procedures
      • 5.1.1.3. Consistent-dosing treatment alternatives
    • 5.1.2. Restraints
      • 5.1.2.1. Rising incident of product recalls
    • 5.1.3. Opportunities
      • 5.1.3.1. Research and development in drug device combination products
      • 5.1.3.2. Technological advancement in drug device combination products
    • 5.1.4. Challenges
      • 5.1.4.1. Complexity and unfavorable regulatory approvals
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Drug Device Combination Products Market, by Product

  • 6.1. Introduction
  • 6.2. Antimicrobial Catheters
  • 6.3. Drug Eluting Stents
  • 6.4. Infusion Pumps
  • 6.5. Inhalers
  • 6.6. Orthopedic Combination Products
  • 6.7. Photodynamic Therapy Devices
  • 6.8. Prefilled Syringes
  • 6.9. Transdermal Patches
  • 6.10. Wound Care Products

7. Drug Device Combination Products Market, by Application

  • 7.1. Introduction
  • 7.2. Antimicrobial Application
  • 7.3. Cancer Treatment
  • 7.4. Cardiovascular Disorder
  • 7.5. Diabetes
  • 7.6. Respiratory Problem

8. Drug Device Combination Products Market, by End-user

  • 8.1. Introduction
  • 8.2. Ambulatory Surgery Centers
  • 8.3. Home Care Settings
  • 8.4. Hospital & Clinic

9. Americas Drug Device Combination Products Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Drug Device Combination Products Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Drug Device Combination Products Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. DRUG DEVICE COMBINATION PRODUCTS MARKET RESEARCH PROCESS
  • FIGURE 2. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 5. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 6. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 7. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. DRUG DEVICE COMBINATION PRODUCTS MARKET DYNAMICS
  • FIGURE 9. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. DRUG DEVICE COMBINATION PRODUCTS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. DRUG DEVICE COMBINATION PRODUCTS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. DRUG DEVICE COMBINATION PRODUCTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 5. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ANTIMICROBIAL CATHETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DRUG ELUTING STENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INHALERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ORTHOPEDIC COMBINATION PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PHOTODYNAMIC THERAPY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PREFILLED SYRINGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TRANSDERMAL PATCHES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY WOUND CARE PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ANTIMICROBIAL APPLICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY CANCER TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY CARDIOVASCULAR DISORDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY RESPIRATORY PROBLEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY HOSPITAL & CLINIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. CHINA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. INDIA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. INDONESIA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. JAPAN DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. MALAYSIA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. PHILIPPINES DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. SINGAPORE DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. SOUTH KOREA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. TAIWAN DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. THAILAND DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. VIETNAM DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. DENMARK DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. EGYPT DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. FINLAND DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. FRANCE DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. GERMANY DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. ISRAEL DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. ITALY DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NETHERLANDS DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. NIGERIA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. NORWAY DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. POLAND DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. QATAR DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. RUSSIA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SAUDI ARABIA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH AFRICA DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SPAIN DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. SWEDEN DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. SWITZERLAND DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. TURKEY DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED ARAB EMIRATES DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED KINGDOM DRUG DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. DRUG DEVICE COMBINATION PRODUCTS MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 152. DRUG DEVICE COMBINATION PRODUCTS MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 153. DRUG DEVICE COMBINATION PRODUCTS MARKET LICENSE & PRICING